Terry-Ann Burrell, Chief Financial Officer at Beam Therapeutics Inc. (BEAM), sold 10,892 shares at $32.12 ($350K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($350k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.12 | 5,446 | $175K | 50.0% |
| 2 | $32.12 | 5,446 | $175K | 50.0% |
| Total | $32.12 avg | 10,892 | $350K | 100% |
| Filing → |
| BEAM | SELL | 2023-01-30 | $3.3M | — | Filing → |
| BEAM | SELL | 2023-01-25 | $1.8M | — | Filing → |
| BEAM | SELL | 2023-01-20 | $4.3M | — | Filing → |